Free shipping on all orders over $ 500

GK921

Cat. No. M9215
GK921 Structure
Size Price Availability Quantity
2mg USD 290  USD290 In stock
5mg USD 430  USD430 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GK921 showed cytotoxicity to RCC (average GI50 in eight RCC cell lines: 0.905 μM). A single treatment with GK921 almost completely reduced tumor growth by stabilizing p53 in the ACHN and CAKI-1 preclinical xenograft tumor models. GK921 rescues p53 levels and consequently induces apoptosis; a concentration-dependent increase in cleaved poly(ADP-ribose) polymerase (c-PARP) and p53 levels is observed.

Chemical Information
Molecular Weight 344.41
Formula C21H20N4O
CAS Number 1025015-40-0
Form Solid
Solubility (25°C) DMSO: ≥ 25 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Kang JH, et al. Cell Death Dis. Discovery of a novel target for renal cell carcinoma: transglutaminase 2.

[2] Kang JH, et al. Cell Death Dis. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.

[3] Ku BM, et al. J Cancer Res Clin Oncol. Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.

Related Glutaminase Products
2-Amino-2-(p-tolyl)acetic acid

2-Amino-2-(p-tolyl)acetic acid is used for optimizing azide skeleton, and is the intermediate in the synthesis of 1,3, 4-thiadiazole compounds.

BJJF078

BJJF078 is an aminopiperidine derivative.

TG53

TG53 is a potent inhibitor of tissue transglutaminase (TG2) and fibronectin (FN) protein-protein interaction.

GLS1 Inhibitor-7

GLS1 Inhibitor-7 is a GLS1 inhibitor (IC50=46.7 μM), with potential anti-cancer, anti-aging and anti-obesity properties.

NC9

NC9 (Cbz-Lys(Acr)-PEG2-dansyl) is an irreversible transglutaminase (TG) inhibitor. NC9 inhibits osteoblast differentiation and mineralization. NC9 destabilizes microtubules. NC9 can be used for the research of osteoblast differentiation.

  Catalog
Abmole Inhibitor Catalog




Keywords: GK921 supplier, Glutaminase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.